These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11963941)

  • 1. Group psychosocial support in metastatic breast cancer.
    Cunningham AJ; Edmonds C
    N Engl J Med; 2002 Apr; 346(16):1247-8; author reply 1247-8. PubMed ID: 11963941
    [No Abstract]   [Full Text] [Related]  

  • 2. Support groups in advanced breast cancer.
    Goodwin PJ
    Cancer; 2005 Dec; 104(11 Suppl):2596-601. PubMed ID: 16247782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group psychosocial support in metastatic breast cancer.
    Nekhlyudov L; Yaker A
    N Engl J Med; 2002 Apr; 346(16):1247-8; author reply 1247-8. PubMed ID: 11961157
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic analysis of psychosocial group therapy in women with metastatic breast cancer.
    Lemieux J; Topp A; Chappell H; Ennis M; Goodwin PJ
    Breast Cancer Res Treat; 2006 Nov; 100(2):183-90. PubMed ID: 16773438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cunning but careless: analysis of a non-replication.
    Kraemer H; Spiegel D
    Psychooncology; 1999; 8(3):273-5. PubMed ID: 10390741
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.
    Spiegel D; Butler LD; Giese-Davis J; Koopman C; Miller E; DiMiceli S; Classen CC; Fobair P; Carlson RW; Kraemer HC
    Cancer; 2007 Sep; 110(5):1130-8. PubMed ID: 17647221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial.
    Kissane D; Li Y
    Cancer; 2008 Jan; 112(2):443-4; author reply 444. PubMed ID: 18058897
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data.
    Bordeleau L; Szalai JP; Ennis M; Leszcz M; Speca M; Sela R; Doll R; Chochinov HM; Navarro M; Arnold A; Pritchard KI; Bezjak A; Llewellyn-Thomas HA; Sawka CA; Goodwin PJ
    J Clin Oncol; 2003 May; 21(10):1944-51. PubMed ID: 12743147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fox guarding the clinical trial: internal vs. external validity in randomized studies.
    Goodwin PJ; Pritchard KI; Spiegel D
    Psychooncology; 1999; 8(3):275. PubMed ID: 10390742
    [No Abstract]   [Full Text] [Related]  

  • 10. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial.
    Kissane DW; Grabsch B; Clarke DM; Smith GC; Love AW; Bloch S; Snyder RD; Li Y
    Psychooncology; 2007 Apr; 16(4):277-86. PubMed ID: 17385190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothesis about Spiegel et al.'s 1989 paper on Psychosocial intervention and breast cancer survival.
    Fox BH
    Psychooncology; 1998; 7(5):361-70. PubMed ID: 9809327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Support groups and metastatic breast cancer: Spiegel et al. (1989).
    Ornish D
    Adv Mind Body Med; 2001; 17(1):19-21. PubMed ID: 11270053
    [No Abstract]   [Full Text] [Related]  

  • 13. Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.
    Bruzzi P; Del Mastro L; Sormani MP; Bastholt L; Danova M; Focan C; Fountzilas G; Paul J; Rosso R; Venturini M
    J Clin Oncol; 2005 Aug; 23(22):5117-25. PubMed ID: 15955906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support groups in breast cancer: when a negative result is positive.
    Goodwin PJ
    J Clin Oncol; 2004 Nov; 22(21):4244-6. PubMed ID: 15452183
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mind matters -- group therapy and survival in breast cancer.
    Spiegel D
    N Engl J Med; 2001 Dec; 345(24):1767-8. PubMed ID: 11742052
    [No Abstract]   [Full Text] [Related]  

  • 17. Platinum-based chemotherapy in metastatic breast cancer: current status.
    Decatris MP; Sundar S; O'Byrne KJ
    Cancer Treat Rev; 2004 Feb; 30(1):53-81. PubMed ID: 14766126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
    Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
    J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cognitive-existential group therapy on survival in early-stage breast cancer.
    Kissane DW; Love A; Hatton A; Bloch S; Smith G; Clarke DM; Miach P; Ikin J; Ranieri N; Snyder RD
    J Clin Oncol; 2004 Nov; 22(21):4255-60. PubMed ID: 15452189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change is complex: rethinking research on psychosocial interventions and cancer.
    Temoshok LR; Wald RL
    Integr Cancer Ther; 2002 Jun; 1(2):135-45. PubMed ID: 14664739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.